Color ultrasound-guided fine-needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients

Haematologica

Volumn 87, Issue 6, 2002, Pages 652-657

  Picardi, Marco ^a   Muretto, Pietro ^a   De Rosa, Gennaro ^a   Selleri, Carmine ^a   De Renzo, Amalia ^a   Persico, Marcello ^a   Rotoli, Bruno ^a  

^a Divisione di Ematologia   (Italy)

Author keywords

Bone marrow transplant; Color ultrasound scan; Liver damage; Percutaneous liver biopsy

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN A; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISONE; RIBAVIRIN; URSODEOXYCHOLIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BILIARY TRACT DISEASE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC SYSTEM TUMOR; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION; MALE; NEEDLE BIOPSY; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME; ULTRASOUND; VIRUS HEPATITIS; COLOR ULTRASOUND FLOWMETRY; CRITICAL ILLNESS; ECHOGRAPHY; INSTRUMENTATION; LIVER DISEASE; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; BIOPSY, NEEDLE; BONE MARROW TRANSPLANTATION; CRITICAL ILLNESS; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0036285646     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: A survey from the European Bone Marrow Transplantation (EBMT) Group - Infectious Diseases Working Party
2. Liver dysfunction in allogeneic bone marrow transplantation recipients
3. Liver disease complicating bone marrow transplantation: A clinical audit
4. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: A 10-year prospective study
5. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia
6. Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis
7. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: Detection by the polymerase chain reaction using multiple primer sets
8. Intestinal and hepatic complications of human bone marrow transplantation. Part I
9. Intestinal and hepatic complications of human bone marrow transplantation. Part II
10. Liver biopsy
11. Color Doppler flow imaging
12. Color Doppler imaging: Principles, limitations, and artifacts
13. Outcome of patients hospitalized for complications after outpatient liver biopsy
14. Histological grading and staging of chronic hepatitis
15. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen
16. Needle liver biopsy in thalassaemia: Analyses of diagnostic accuracy and safety in 1184 consecutive biopsies
17. A 21-year experience with major hemorrhage after percutaneous liver biopsy
18. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation
19. Intrahepatic hematoma: A complication of percutaneous liver biopsy
20. Etiology of fulminant hepatic failure: Is another virus involved?
21. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver
22. The hepatologist in the haematologists' camp
23. Hepatitis C infection among survivors of childhood cancer
24. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
25. Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: A useful tool to effect changes in management
26. Transjugular liver biopsy in BMT
27. Reduced intensity thiotepacyclophosphamide conditioning for allogeneic haemapoietic stem cell transplants (HSCT) in patients up to 60 years of age